Skip to main content

Sun Pharma Adv. Res

Healthcare NSE:SPARC

131.45INR
19.56 ( 17.48%)

Last update at March 25, 2026, midnight

Day Range

112.55133.70
LowHigh

52 Week Range

109.30 204.40
LowHigh

Fundamentals

  • Previous Close 111.89
  • Market Cap 43855.85M
  • Volume13,840,637
  • P/E Ratio -
  • EBITDA -2467.48M
  • Revenue TTM 595.96M
  • Revenue Per Share TTM 1.84
  • Gross Profit TTM 310.06M
  • Diluted EPS TTM -8.23

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Past Performance

Status Stocks Entry Price Entry Date Exit Date Duration Duration Type Sector *Return(%)
CLOSED CIPLA ₹ 1515.70 4/11/25 4/11/25 Same Day Short Term Healthcare -0.79%
CLOSED CIPLA ₹ 1499.85 18/03/25 18/03/25 Same Day Short Term Healthcare 0.72%
CLOSED CIPLA ₹ 1452.00 11/03/25 11/03/25 Same Day Short Term Healthcare 0.69%
CLOSED CIPLA ₹ 1457.00 14/02/25 14/02/25 Same Day Short Term Healthcare 0.24%

Financials

Income Statement

Total Revenue
Net Income

Balance Sheet

Total Assets
Total Liabilities

Change in Cash

Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Income before tax -3427.80M -3868.32M -2225.80M -2033.95M -1511.39M
Net income -3425.10M -3872.14M -2225.80M -2033.95M -1511.39M
Total Revenue 717.70M 755.45M 2387.80M 1372.49M 2529.57M
Gross Profit 486.50M -1238.24M 821.21M 105.52M 465.55M
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Total assets 3355.30M 5150.42M 8301.20M 2800.83M 2296.90M
Intangible assets 536.50M 427.12M 254.70M 231.16M 6.85M
Other current assets 81.70M 938.52M 150.70M 273.40M 264.20M
Deferred long term liab - - - - -
Non current assets other - - - - -
Breakdown 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Change in Cash -33.70M 47.46M -6.40M -80.80M 89.52M
Operating Cash -3602.90M -4291.88M -691.20M -2082.33M -1518.96M
Free Cash Flow -3706.30M -4556.96M -845.10M -2409.10M -1578.91M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change Price Market Cap (M) P/E Ratio
SPARC
Sun Pharma Adv. Res 		19.56 17.48% 131.45 43855.85 -
SUNPHARMA
Sun Pharmaceutical Industries Limited 		42.10 2.40% 1795.40 4224508.76 40.32
DIVISLAB
Divi's Laboratories Limited 		-11.50 -0.19% 6014.50 1752225.28 70.47
TORNTPHARM
Torrent Pharmaceuticals Limited 		40.90 0.96% 4297.50 1362716.66 63.48
CIPLA
Cipla Limited 		25.00 2.05% 1244.40 1183505.97 21.74

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data ("EODHD") on an 'as is' basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.